treating people with hepatitis C all along and should be given leeway to
prescribe the new drug Sovaldi.
Two groups representing most of America’s HIV doctors have challenged
moves by insurance companies to keep them from prescribing lifesaving
hepatitis C medications.
Insurers are requiring doctors
prescribing sofosbuvir (Sovaldi), a once-daily pill for hepatitis C, to
either be hepatologists or gastroenterologists. Those doctors specialize
in issues related to the liver, which hepatitis C destroys.
But hepatitis C is often transmitted along with HIV, so HIV doctors have long been treating their patients for both conditions.